Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Lenox Hill Hospital located at 100 E 77Th St, New York, NY, 10021 & includes data from NPIs 1477616571
Dexur analyzed Q1 2018 (January to March 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for Lenox Hill Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 1,866 | 1,787 | ||||||||||
Surgical | 741 | 727 | ||||||||||
Non Surgical | 1,125 | 1,060 | ||||||||||
Cardiovascular | 504 | 494 | ||||||||||
General Medicine | 297 | 271 | ||||||||||
Orthopedics | 230 | 224 | ||||||||||
General Surgery | 157 | 153 | ||||||||||
Gastroenterology & Endocrinology | 121 | 113 | ||||||||||
Urology | 120 | 118 | ||||||||||
Pulmonology | 116 | 109 | ||||||||||
Neurology | 104 | 98 | ||||||||||
Oncology & Hematology | 63 | 57 | ||||||||||
Psychiatry & Mental Disorders | 52 | 52 | ||||||||||
Spine | 43 | 42 | ||||||||||
Colorectal | 19 | 19 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 17 | 15 | ||||||||||
Obstetrics & Gynecology | 13 | 12 |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coronary Bypass | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Acute Myocardial Infarction |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
Craniotomy And Endovascular Intracranial Procedures |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
G.I. Obstruction |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
Degenerative Nervous System Disorders |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cervical Spinal Fusion |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures |
Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jan 2018 to Mar 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures |